Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Brightline Interactive, Inc./NVGGRP · Entity 7612 | Director | July 10, 2026 | August 06, 2026 |
| G3 VRM Acquisition Corp.GGGV · Entity 137493 | Director | June 30, 2021 | June 30, 2021 |
| GP STRATEGIES CORPGPX · Entity 134545 | Director | October 14, 2021 | October 18, 2021 |
| PETMED EXPRESS INCPETS · Entity 7326 | Director | September 17, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Brightline Interactive, Inc./NV
Report date July 10, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 · Expires 2036-07-10 | Direct | 174,368 |
Reported balance
After 2026-07-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-10 · Grant · Acquired 174,368 · Balance 174,368 F1: This option vests in equal monthly installments over a one-year period commencing on the grant date. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.69 · Expires 2036-05-01 | Direct | 145,000 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 145,000 F2: This option vested with respect to 60,422 shares on 5/31/2026, and the remainder vests in equal monthly increments from 6/30/2026 through 12/31/2026. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.25 · Expires 2035-01-01 | Direct | 37,500 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 37,500 F3: This option has fully vested as of the date of this report. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.50 · Expires 2034-05-01 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-07-10 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 20,000 F3: This option has fully vested as of the date of this report. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests in equal monthly installments over a one-year period commencing on the grant date.
F2: This option vested with respect to 60,422 shares on 5/31/2026, and the remainder vests in equal monthly increments from 6/30/2026 through 12/31/2026.
F3: This option has fully vested as of the date of this report.
G3 VRM Acquisition Corp.
Report date June 30, 2021 · Filed June 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common Stock, par value $0.0001 per shareSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-06-30 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the Issuer's registration statement on Form S-1 (File No. 333-255226) under the heading "Description of Securities--Founder Shares and Private Placement Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the holder, on a one-for-one basis, subject to certain adjustments described therein and have no expiration date. F2: These shares will be forfeited if Ms. Elkeles does not remain on the Board of Directors through the date of the Company's initial business combination. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the Issuer's registration statement on Form S-1 (File No. 333-255226) under the heading "Description of Securities--Founder Shares and Private Placement Shares", the shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the holder, on a one-for-one basis, subject to certain adjustments described therein and have no expiration date.
F2: These shares will be forfeited if Ms. Elkeles does not remain on the Board of Directors through the date of the Company's initial business combination.
GP STRATEGIES CORP
Report date October 14, 2021 · Filed October 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-10-14 transaction · row 1
1 source rowRow 1 · 2021-10-14 · Disposition to issuer · Disposed 13,584 · Balance 0 F1: On July 15, 2021, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Learning Technologies Group plc, a public limited company incorporated in England and Wales ("LTG"), Learning Technologies Acquisition Corporation, a Delaware corporation and direct wholly owned subsidiary of LTG ("US Holdco"), and Gravity Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of US Holdco ("Merger Sub"), pursuant to which each share of common stock of the Issuer was converted into the right to receive a cash payment equal to the per share merger consideration of $20.85. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 15, 2021, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Learning Technologies Group plc, a public limited company incorporated in England and Wales ("LTG"), Learning Technologies Acquisition Corporation, a Delaware corporation and direct wholly owned subsidiary of LTG ("US Holdco"), and Gravity Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of US Holdco ("Merger Sub"), pursuant to which each share of common stock of the Issuer was converted into the right to receive a cash payment equal to the per share merger consideration of $20.85.
PETMED EXPRESS INC
Report date September 17, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,923 |
Reported balance
After 2026-09-17 transaction · row 1
1 source rowRow 1 · 2026-09-17 · Grant · Acquired 49,923 · Balance 49,923 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 21, 2026 12:58 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 49,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-26-000051 · wk-form4_1789995525.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,923 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors. Read SEC document |
| July 10, 2026 Filed Aug 6, 2026 20:32 UTC | Brightline Interactive, Inc./NV GGRP · Entity 7612 | GrantStock Option (Right to Buy) · Derivative | 174,368 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0000891839-26-000324 · form4.xml · derivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,368 Underlying: Common Stock · 174,368 shares Expires 2036-07-10 F1 · derivative.exercise_date: This option vests in equal monthly installments over a one-year period commencing on the grant date. Read SEC document |
| May 01, 2026 Filed Jun 18, 2026 20:17 UTC | Brightline Interactive, Inc./NV GGRP · Entity 7612 | GrantStock Option (Right to Buy) · Derivative | 145,000 | $0.00 Strike: $0.69 | $0.00 |
DisclosureSEC source: 0000891839-26-000251 · form4.xml · derivative · entry 2 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,000 Underlying: Common Stock · 145,000 shares Expires 2036-05-01 F2 · derivative.exercise_date: This option vests with respect to 60,422 shares on 5/31/2026, then vests in equal monthly increments from 6/30/2026 through 12/31/2026. Read SEC document |
| January 01, 2025 Filed Jun 18, 2026 20:17 UTC | Brightline Interactive, Inc./NV GGRP · Entity 7612 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0000891839-26-000251 · form4.xml · derivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2035-01-01 F1 · derivative.exercise_date: This option vests in equal monthly increments from 1/31/2025 through 12/31/2025. Read SEC document |
| April 29, 2024 Filed Jun 4, 2024 16:58 UTC | Brightline Interactive, Inc./NV VRAR · Entity 7612 | GrantStock Option (Right to Purchase) · Derivative | 20,000 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001493152-24-022504 · ownership.xml · derivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2034-04-29 F1 · kind: On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested. F1 · shares: On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested. F1 · derivative.exercise_date: On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested. F1 · derivative.underlying_shares: On April 27, 2024, the board of directors (the "Board") of The Glimpse Group, Inc. (the "Company"), appointed Dr. Elkeles to the Board, and in connection therewith, agreed to grant to Dr Elkeles, under the Company's 2016 Incentive Plan, options ("Options") to purchase an aggregate of 20,000 shares of the Company's common stock, as compensation for her service on the Board for the remainder of the calendar year ending December 31, 2024. The Options vest in monthly increments beginning April 29, 2024 through December 31, 2024, and are exercisable for $2.50 per share. The Options are deemed exercisable when, and to the extent, they become vested. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 15:18 UTC | GP STRATEGIES CORP GPX · Entity 134545 | Disposition to issuerCommon Stock | 13,584 | $20.85 | $283,226.40 |
DisclosureSEC source: 0000070415-21-000140 · wf-form4_163458470087139.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On July 15, 2021, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Learning Technologies Group plc, a public limited company incorporated in England and Wales ("LTG"), Learning Technologies Acquisition Corporation, a Delaware corporation and direct wholly owned subsidiary of LTG ("US Holdco"), and Gravity Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of US Holdco ("Merger Sub"), pursuant to which each share of common stock of the Issuer was converted into the right to receive a cash payment equal to the per share merger consideration of $20.85. F1 · price: On July 15, 2021, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Learning Technologies Group plc, a public limited company incorporated in England and Wales ("LTG"), Learning Technologies Acquisition Corporation, a Delaware corporation and direct wholly owned subsidiary of LTG ("US Holdco"), and Gravity Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of US Holdco ("Merger Sub"), pursuant to which each share of common stock of the Issuer was converted into the right to receive a cash payment equal to the per share merger consideration of $20.85. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 13:53 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 544 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-21-000121 · wf-form4_163337001708582.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,584 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended September 30, 2021 paid in shares of the Registrant's Common Stock. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 11:40 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 714 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-21-000093 · wf-form4_162515398213295.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,040 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended June 30, 2021 paid in shares of the Registrant's Common Stock. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 16:33 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 641 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-21-000048 · wf-form4_161739557928691.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,326 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended March 31, 2021 paid in shares of the Registrant's Common Stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 16:34 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 1,515 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-21-000010 · wf-form4_160988247205990.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,685 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended December 31, 2020 paid in shares of the Registrant's Common Stock. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 16:31 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-20-000153 · wf-form4_160167068372737.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,170 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended September 30, 2020 paid in shares of the Registrant's Common Stock. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 13:45 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 2,086 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-20-000097 · wf-form4_159371193153292.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,262 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended June 30, 2020 paid in shares of the Registrant's Common Stock. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 09:03 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 1,758 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-20-000053 · wf-form4_158583258601357.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,176 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended March 31, 2020 paid in shares of the Registrant's Common Stock. Read SEC document |
| December 30, 2019 Filed Jan 2, 2020 14:15 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 859 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-20-000009 · wf-form4_157799251560003.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,418 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended December 31, 2019 paid in shares of the Registrant's Common Stock. Read SEC document |
| September 30, 2019 Filed Oct 4, 2019 16:08 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-19-000110 · wf-form4_157021967192528.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,559 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended September 30, 2019 paid in shares of the Registrant's Common Stock. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 16:55 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 781 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-19-000091 · wf-form4_156210091823532.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,712 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended June 30, 2019 paid in shares of the Registrant's Common Stock. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 15:29 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 931 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-19-000057 · wf-form4_155423333779179.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,931 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended March 31, 2019 paid in shares of the Registrant's Common Stock. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 16:11 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-19-000034 · wf-form4_154654986746063.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended December 31, 2018 paid in shares of the Registrant's Common Stock. Read SEC document |
| September 28, 2018 Filed Oct 2, 2018 11:24 UTC | GP STRATEGIES CORP GPX · Entity 134545 | GrantCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0000070415-18-000137 · wf-form4_153849386732654.xml · nonDerivative · entry 1 Elkeles Tamar · CIK 0001750083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · price: Represents a portion of the quarterly Director fees for the quarter ended September 30, 2018 paid in shares of the Registrant's Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.